Tarik A. Khan

1.7k total citations
21 papers, 1.3k citations indexed

About

Tarik A. Khan is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tarik A. Khan has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tarik A. Khan's work include Protein purification and stability (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and T-cell and B-cell Immunology (4 papers). Tarik A. Khan is often cited by papers focused on Protein purification and stability (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and T-cell and B-cell Immunology (4 papers). Tarik A. Khan collaborates with scholars based in Switzerland, United States and Germany. Tarik A. Khan's co-authors include Sai T. Reddy, Ravuri S. K. Kishore, Hanns‐Christian Mahler, Simon Friedensohn, Jennifer A. Maynard, Kea Martin, Hans Kreipe, Ulrike Nitz, Matthias Kreuzaler and Philipp Müller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Tarik A. Khan

21 papers receiving 1.2k citations

Peers

Tarik A. Khan
Koon Y. Pak United States
Jared S. Bee United States
Margaret Speed Ricci United States
Attila Jenei Hungary
Eric Krauland United States
Mark Castanares United States
Mohammad Rashidian United States
Kamil Godula United States
Ryan Fleming United States
Koon Y. Pak United States
Tarik A. Khan
Citations per year, relative to Tarik A. Khan Tarik A. Khan (= 1×) peers Koon Y. Pak

Countries citing papers authored by Tarik A. Khan

Since Specialization
Citations

This map shows the geographic impact of Tarik A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarik A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarik A. Khan more than expected).

Fields of papers citing papers by Tarik A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarik A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarik A. Khan. The network helps show where Tarik A. Khan may publish in the future.

Co-authorship network of co-authors of Tarik A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Tarik A. Khan. A scholar is included among the top collaborators of Tarik A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarik A. Khan. Tarik A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winter, Martin, Franziska Zähringer, Tarik A. Khan, et al.. (2023). Identification of Hetero-aggregates in Antibody Co-formulations by Multi-dimensional Liquid Chromatography Coupled to Mass Spectrometry. Analytical Chemistry. 95(4). 2203–2212. 11 indexed citations
2.
Khan, Tarik A., et al.. (2023). High concentration formulation developability approaches and considerations. mAbs. 15(1). 2211185–2211185. 39 indexed citations
4.
Page, Susanne, et al.. (2022). Patient Centricity Driving Formulation Innovation: Improvements in Patient Care Facilitated by Novel Therapeutics and Drug Delivery Technologies. The Annual Review of Pharmacology and Toxicology. 62(1). 341–363. 14 indexed citations
5.
Zhang, Zhenhuan, Ann Marie Woys, Kunlun Hong, et al.. (2020). Adsorption of non-ionic surfactant and monoclonal antibody on siliconized surface studied by neutron reflectometry. Journal of Colloid and Interface Science. 584. 429–438. 32 indexed citations
6.
Grapentin, Christoph, Claudia Müller, Ravuri S. K. Kishore, et al.. (2020). Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188. Journal of Pharmaceutical Sciences. 109(8). 2393–2404. 43 indexed citations
7.
Salazar‐Fontana, Laura I., Dharmesh D. Desai, Tarik A. Khan, et al.. (2017). Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development. The AAPS Journal. 19(2). 377–385. 32 indexed citations
8.
Correa, Wilmar, et al.. (2017). Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon. International Journal of Molecular Sciences. 18(12). 2737–2737. 20 indexed citations
9.
Khan, Tarik A., et al.. (2016). Accurate and predictive antibody repertoire profiling by molecular amplification fingerprinting. Science Advances. 2(3). e1501371–e1501371. 87 indexed citations
10.
Friedensohn, Simon, Tarik A. Khan, & Sai T. Reddy. (2016). Advanced Methodologies in High-Throughput Sequencing of Immune Repertoires. Trends in biotechnology. 35(3). 203–214. 86 indexed citations
11.
Khan, Tarik A., Xianzhe Wang, & Jennifer A. Maynard. (2016). Inclusion of an RGD Motif Alters Invasin Integrin-Binding Affinity and Specificity. Biochemistry. 55(14). 2078–2090. 6 indexed citations
12.
Müller, Philipp, Matthias Kreuzaler, Tarik A. Khan, et al.. (2015). Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade. Science Translational Medicine. 7(315). 315ra188–315ra188. 269 indexed citations
13.
Glanville, Jacob, Sara D’Angelo, Tarik A. Khan, et al.. (2015). Deep sequencing in library selection projects: what insight does it bring?. Current Opinion in Structural Biology. 33. 146–160. 60 indexed citations
14.
Khan, Tarik A., Hanns‐Christian Mahler, & Ravuri S. K. Kishore. (2015). Key interactions of surfactants in therapeutic protein formulations: A review. European Journal of Pharmaceutics and Biopharmaceutics. 97(Pt A). 60–67. 227 indexed citations
15.
Khan, Tarik A., Roland Schmidt, Christof Finkler, et al.. (2015). Determination of the Density of Protein Particles Using a Suspended Microchannel Resonator. Journal of Pharmaceutical Sciences. 104(12). 4034–4040. 27 indexed citations
16.
Greiff, Victor, Ulrike Menzel, Ulrike Haessler, et al.. (2014). Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice. BMC Immunology. 15(1). 40–40. 51 indexed citations
17.
Menzel, Ulrike, Victor Greiff, Tarik A. Khan, et al.. (2014). Comprehensive Evaluation and Optimization of Amplicon Library Preparation Methods for High-Throughput Antibody Sequencing. PLoS ONE. 9(5). e96727–e96727. 39 indexed citations
18.
Khan, Tarik A. & Sai T. Reddy. (2013). Immunological principles regulating immunomodulation with biomaterials. Acta Biomaterialia. 10(4). 1720–1727. 17 indexed citations
19.
Panthani, Matthew G., Tarik A. Khan, Dariya K. Reid, et al.. (2013). In Vivo Whole Animal Fluorescence Imaging of a Microparticle-Based Oral Vaccine Containing (CuInSexS2–x)/ZnS Core/Shell Quantum Dots. Nano Letters. 13(9). 4294–4298. 88 indexed citations
20.
Miller, Maria A., Tarik A. Khan, Brian K. Wilson, et al.. (2012). Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and In Vivo bioavailability. Journal of Pharmaceutical Sciences. 101(10). 3763–3778. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026